NewLink says Ebola vaccine trial could start in weeks

NewLink Genetics Corp, which licensed an Ebola vaccine developed byCanadian government scientists, has enough doses on hand to launch the first human safety trial of an Ebola vaccine this summer, its chief executive said on Wednesday. By Sharon Begley for Reuters.